Compare ASC & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASC | BWAY |
|---|---|---|
| Founded | 2010 | 2003 |
| Country | Bermuda | Israel |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 508.7M | 450.8M |
| IPO Year | 2013 | N/A |
| Metric | ASC | BWAY |
|---|---|---|
| Price | $15.26 | $13.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $15.00 | $13.25 |
| AVG Volume (30 Days) | ★ 747.3K | 151.4K |
| Earning Date | 05-06-2026 | 03-11-2026 |
| Dividend Yield | ★ 1.95% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $301.23 |
| Revenue Next Year | N/A | $24.33 |
| P/E Ratio | ★ $16.60 | $81.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.32 | $7.84 |
| 52 Week High | $16.91 | $26.63 |
| Indicator | ASC | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | 54.53 | 33.52 |
| Support Level | $10.00 | $11.55 |
| Resistance Level | $16.91 | $14.65 |
| Average True Range (ATR) | 0.65 | 0.72 |
| MACD | -0.06 | 0.16 |
| Stochastic Oscillator | 66.04 | 68.49 |
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The Company operates its business in one operating segment, the transportation of refined petroleum products and chemicals.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.